TTK Healthcare Ltd.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

TTK Healthcare Ltd. has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend as of April 2026. Despite a modest day gain of 1.54%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other key metrics, reflecting cautious investor sentiment amid broader market challenges.

TTK Healthcare Ltd., a micro-cap player in the diversified sector, has experienced a notable shift in its technical momentum, with multiple indicators signalling a bearish trend. The stock’s recent price action and technical parameters suggest increasing downside pressure, reflecting a deteriorating outlook amid broader market challenges.

TTK Healthcare Ltd., a micro-cap player in the diversified sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest daily gain of 2.09%, the stock’s broader trend remains cautiously bearish, prompting a recent downgrade from Hold to Sell by MarketsMOJO on 21 July 2025.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

While the broader market shows signs of recovery, TTK Healthcare Ltd. has continued its downward trajectory, hitting a fresh 52-week low of Rs 743.05 on 30 Mar 2026. This decline comes amid a backdrop of mixed financial signals and persistent underperformance relative to benchmarks.

TTK Healthcare Ltd. has reached a new 52-week low of Rs.758.4 on 27 March 2026, marking a significant decline in its share price amid broader market weakness and persistent underperformance relative to benchmarks and peers.

TTK Healthcare Ltd. has reached a new 52-week low of Rs.765 on 25 March 2026, marking a significant decline amid a sustained period of underperformance. The stock has experienced a consecutive five-day fall, culminating in a cumulative loss of 6.09% over this period, reflecting ongoing pressures within the diversified sector.

TTK Healthcare Ltd. witnessed its stock price decline to a fresh 52-week low of Rs.781.5 on 24 March 2026, marking a significant downturn amid broader market volatility and company-specific performance concerns.

TTK Healthcare Ltd. has reached a new 52-week low of Rs. 795.95 on 23 March 2026, marking a significant decline in the stock’s valuation amid a sustained period of underperformance relative to its sector and benchmark indices.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

TTK Healthcare Ltd. has reached a significant milestone by touching its 52-week low price of Rs 807.05, marking a notable decline in the stock’s valuation over the past year. This drop reflects ongoing challenges in the company’s financial performance and market positioning within the diversified sector.

TTK Healthcare Ltd. has reached a new 52-week low, closing at Rs.815.05 on 16 Mar 2026, marking a significant decline amid broader market weakness and company-specific performance concerns.

TTK Healthcare Ltd. witnessed a significant decline today, hitting a new 52-week low of Rs.831.05. The stock underperformed its sector and broader market indices amid a generally bearish market environment, reflecting ongoing concerns about its recent financial performance and valuation metrics.

TTK Healthcare Ltd. has recently touched a 52-week low, closing just 3.01% above its lowest price of Rs 839. The stock’s decline reflects ongoing pressures, with the share price falling to an intraday low of Rs 844.75 and trading below all key moving averages, signalling a sustained bearish trend.

TTK Healthcare Ltd. has declined to a fresh 52-week low of Rs.839, marking a significant downturn in its stock performance amid broader market weakness and subdued company fundamentals.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

TTK Healthcare Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.